We are an alliance, an accelerator, a campus, and a movement that has made the Richmond-Petersburg region in Central Virginia a globally competitive ecosystem for manufacturing critically important medicines within the United States.
What We Do
The Alliance for Building Better Medicine accelerates the growth and success of the industry. In this way, we help firms and researchers reduce the cost of manufacturing pharmaceuticals by employing novel chemical and engineering innovations to improve the way critical medicines are made in the U.S. Leveraging continuous-flow and other advanced manufacturing technologies, we streamline the processes for creating high-quality generic medicines in the U.S. more quickly and less expensively, with significantly lower environmental impact. As an alliance, we power many facets working together to impact the region’s R&D, advanced pharmaceutical manufacturing, workforce development, and supply chain development. The result of our collaboration is clear. The innovation occurring as part of the Alliance’s mission is driving opportunities far beyond chemistry, engineering, and manufacturing systems and processes. Together, we’re creating the social and economic structures and systems for identifying and meeting the needs of all communities.
What Drives Us
To bring this purpose to life, our collective actions are driven by a unifying vision for a healthy, equitable, and globally competitive nation where everyone has safe and secure access to affordable, high-quality medicines that are essential and urgently needed to ensure the health of all communities at home and around the globe.
Driving this vision forward is a clear mission – to serve as the world’s central access point for advanced pharmaceutical manufacturing and R&D where affordable, high-quality medicines are researched, accelerated, and sustainably created in the U.S. from start to finish as part of a new era of health and wellness.
The Alliance is committed to diversity, equity, inclusion and access (DEIA) and will build on existing opportunities for underserved individuals in the Richmond-Petersburg Region and surrounding rural areas through its implementation of an Equity Action Plan.
In the News
Ensuring the health of all communities
SOURCE International Trade Administration"In Petersburg, Under Secretary Lago will tour the newly constructed Civica Rx facility, a non-profit generic drug company that will manufacture affordable essential medicines and is a member of the Alliance for Building Better...
SOURCE Richmond Times-Dispatch by Sean Jones"Richmond pharmaceutical company Phlow Corp. has closed on a $36.1 million fundraising round targeted at growing its research and development capabilities. The funding comes through several undisclosed sources, though Phlow...
Activation Capital Gets $15M From State for Richmond Innovation Center, Medicine Manufacturing Initiative
SOURCE Richmond InnoIMAGE Activation Capital"Virginia Gov. Glenn Youngkin on Tuesday announced $66.7 million in grant funding for life sciences projects in the state, including a $15 million tranche for Activation Capital. The Richmond organization, which bills itself...